GSK
EMA publishes updated diabetes guidelines
July 2, 2012Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda
The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …
Witty warns EU leaders over pricing
June 27, 2012Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing
Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …
Pharma companies share $400m US biosecurity contract
June 26, 2012Manufacturing and Production Emergent BioSolutions, GSK, Novartis, manufacturing
GlaxoSmithKline, Novartis and Emergent BioSolutions will share a $400 million contract from the US government to provide vaccine manufacturing capacity …
GSK partners with Cambridge University
June 18, 2012Research and Development, Sales and Marketing ABPI, Cambridge, GSK, R&D
The University of Cambridge begins a new collaboration with GlaxoSmithKline today to advance drug discovery and the development of new …
PMCPA reprimands Chiesi for multiple breaches
June 18, 2012Sales and Marketing COPD, Chiesi, GSK, PMCPA, code
Chiesi has been publicly reprimanded by the PMCPA part for promoting its asthma drug Fostair off-label. The embarrassing slapdown from …
GSK pays £146 million for eczema drug
June 13, 2012Sales and Marketing Basilea, GSK, Stiefel, Toctino
GlaxoSmithKline has paid £146 million for Basilea Pharmaceutica’s dermatology drug Toctino. Toctino (alitretinoin) is approved for the treatment of adults …
Lilly app aims to boost trial recruitment
June 8, 2012Medical Communications GSK, clinical trials, lilly, oncology
Lilly has launched a new searchable clinical trial mobile app for oncologists. The app is available for the iPad and …
HGS shareholder challenges ‘poison pill’
May 31, 2012Sales and Marketing Benlysta, GSK, HGS, hostile bid
The saga of GlaxoSmithKline’s attempt to take over Human Genome Sciences (HGS) has taken another turn with legal action by …
Photo story: GSK’s 2012 legacy
May 30, 2012Research and Development Andrew Witty, GSK, Olympics 2012
Tuesday May 29, 2012: GlaxoSmithKline chief executive, Sir Andrew Witty makes a speech at a conference at the company’s headquarters …
GSK starts combination trial for melanoma
May 30, 2012Research and Development, Sales and Marketing GSK, R&D, Roche, Zelboraf, melanoma
GlaxoSmithKline has begun a combination trial for two of its investigational skin cancer drugs. The firm will combine dabrafenib, its …
Public-private alliance to discover new antibiotics
May 25, 2012AstraZeneca, EFPIA, GSK, Janssen, Sanofi, antibiotic, bacterial infection
A Europe-wide public-private partnership is to put €224m (£180m) into finding new antibiotics for all manner of bacterial infections such …
Ovarian cancer charity wins GSK/King’s Fund award
May 21, 2012Medical Communications, Sales and Marketing GSK, awards, charity, king's fund, ovarian cancer
A charity which aims to increase the chances of survival for patients with a poorly-treated form of cancer is to …
GSK buys more of Theravance
May 18, 2012Research and Development, Sales and Marketing COPD, Cellzome, GSK, Relovair, Theravance
GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …
GlaxoSmithKline to acquire Cellzome for £61 million
May 15, 2012Research and Development, Sales and Marketing Cellzome, Domantis, GSK, R&D
GlaxoSmithKline will expand its platform technology capability with the acquisition of a chemical proteomics company. GSK will acquire those shares …
GSK raises bid for Human Genome Services
May 9, 2012Research and Development, Sales and Marketing GSK, Human Genome Services, bid, takeover
The latest round in GlaxoSmithKline’s attempt to take over Human Genome Services has begun with GSK appealing directly to the …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
